ID | 115734 |
著者 |
Iraha, Satoshi
RIKEN|Kumamoto University|Kyoto University
Tu, Hung-Ya
RIKEN
Yamasaki, Suguru
RIKEN|Sumitomo Dainippon Pharma
Kagawa, Takahiro
Animal Resources and Technical Research Center
Goto, Motohito
Animal Resources and Technical Research Center
Takahashi, Riichi
Animal Resources and Technical Research Center
Watanabe, Takehito
RIKEN
Sugita, Sunao
RIKEN
Sunagawa, Genshiro A.
RIKEN
Matsuyama, Take
RIKEN
Fujii, Momo
RIKEN
Kuwahara, Atsushi
Sumitomo Dainippon Pharma
Kishino, Akiyoshi
Sumitomo Dainippon Pharma
Koide, Naoshi
RIKEN
Eiraku, Mototsugu
RIKEN
Tanihara, Hidenobu
Kumamoto University
Takahashi, Masayo
RIKEN|Kyoto University
Mandai, Michiko
RIKEN
|
資料タイプ |
学術雑誌論文
|
抄録 | Increasing demand for clinical retinal degeneration therapies featuring human ESC/iPSC-derived retinal tissue and cells warrants proof-of-concept studies. Here, we established two mouse models of end-stage retinal degeneration with immunodeficiency, NOG-rd1-2J and NOG-rd10, and characterized disease progress and immunodeficient status. We also transplanted human ESC-derived retinal sheets into NOG-rd1-2J and confirmed their long-term survival and maturation of the structured graft photoreceptor layer, without rejection or tumorigenesis. We recorded light responses from the host ganglion cells using a multi-electrode array system; this result was consistent with whole-mount immunostaining suggestive of host-graft synapse formation at the responding sites. This study demonstrates an application of our mouse models and provides a proof of concept for the clinical use of human ESC-derived retinal sheets.
|
掲載誌名 |
Stem Cell Reports
|
ISSN | 22136711
|
出版者 | International Society for Stem Cell Research|Cell Press
|
巻 | 10
|
号 | 3
|
開始ページ | 1059
|
終了ページ | 1074
|
発行日 | 2018-03-01
|
権利情報 | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
|
EDB ID | |
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|
部局 |
医学系
|